alexa Challenges and Opportunities for Synthetic Biology in India | OMICS International
ISSN: 2332-0737
Current Synthetic and Systems Biology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Challenges and Opportunities for Synthetic Biology in India

Singh V1*, Jain R2 and Dhar PK3

1Synth-Bio Group, Institute of Systems & Synthetic Biology, Université d'Évry Val d'Essonne, Genopole Campus 1, Batiment Genavenir 6, 5 rue Henri Desbruères, 91030 Évry, France

2UNESCO-IHE, Westvest 7, Delft, 2611 AX, The Netherlands

3Department of Life Sciences, Shiv Nadar University, Dadri, Gautam Budh Nagar, 203207, India

*Corresponding Author:
Vijai Singh
Synth-Bio Group
Institute of Systems & Synthetic Biology
Université d'Évry Val d'Essonne Genopole Campus 1
Batiment Genavenir 6, 5 rue Henri Desbruères
91030 Évry, France
Tel: +33 169475381
Fax: +33 169474437
E-mail: [email protected]

Received date: November 17, 2014; Accepted date: November 20, 2014; Published date: November 22, 2014

Citation: Singh V, Jain R, Dhar PK (2014) Challenges and Opportunities for Synthetic Biology in India. Curr Synthetic Sys Biol 2:e112. doi:10.4172/2332-0737.1000e112

Copyright: © 2014 Singh V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Current Synthetic and Systems Biology

Editorial

There is an unprecedented increase in the infectious, cancer, neurological and heredity diseases in humans worldwide. Food and energy scarcity are also a major concern. India is the second-most populous country with over 1.25 billion peoples in the world. Large number of Indian population do not have access to sufficient quantity of quality food, nutrients, drugs, vaccines, clean water – to name a few. Indian scientists are trying to tackle these challenges. However, simple conventional technologies are not sufficient to find solutions to these problems and a more modern approach is required.

Synthetic biology (SB) is a newly emerging area where engineering principles are applied in the biology. It is defined as “design and construction of new biological parts, devices, and systems, or re-design of existing, natural biological systems for useful purposes.”

Synthetic biology is a fast growing area where many discipline such as physics, chemistry, mathematics, engineering and computer science are applied together. It plays a key role in the improvement and establishment of synthetic gene networks and biosynthetic pathway for better understanding of cellular mechanisms. It is also helpful in sufficient production of valuable products for the prevention of diseases. An initial initiative of synthetic biology has been taken by American and European scientists who have designed a number of synthetic gene circuits by using synthetic genetic parts with well-defined functions. Recently, the groundbreaking research has been done by J.C. Venter and colleagues on the creation of first synthetic cell Mycoplasma mycoides JCVI-syn1.0. This experiment has proved that genomes can be designed in the computers which were further chemically synthesized and then created a new designer organism [1].

First synthetic genetic devices such as Repressilator [2] and Toggle switch [3] have been successfully designed and well-characterized in Escherichia coli. Later, Registry of Standard Biological Parts- MIT, USA (partsregistry.org) has established and standardized the genetic parts which are freely available to scientific community. In recent years, a number of synthetic genetic parts, device and circuit including promoter [4,5], regulatory proteins and RNAs [6-10], scaffolds [11], oscillators [2,12-14], riboregulators [15-18], riboswitches [19,20], toggle switch [3] and biologic gates [21-25] that have been successfully engineered and characterized in a wide range of hosts including mammalians.

Though, globally research in synthetic biology and its application are on high priority, India is lagging behind in this field of research and an urgent need arises to promote and accelerate the synthetic biology research in India. It holds a key to solve many challenges such as food & energy scarcity and drugs against incurable diseases. Thus, initiative should be taken by Indian scientists to design, construct and characterize the novel synthetic genetic parts, devices and circuits for reprogramming of cellular machinery with predictive function. These engineered organisms should be robust, fast, and efficient for production of value-added products for controlling the diseases. More recently in order to edit or correct the genome, CRISPR, a powerful tool which has been applied for genome editing of bacteria and archaea [26,27], zebrafish [28], C. Elegans [29] eukaryotes including human [30,31], should be used in development of new products using synthetic biology. It has also been used not only for controlling of pathogenic bacteria but also for cancer and genetic therapy [32,33].

Thus, we need to establish a national repository centre for synthetic genetic parts, device and circuits that should be easily accessible and can be used for designing and engineering of organisms with predictive properties. Ideally, all these genetic parts should be easily exchangeable and useful for production of any kinds of value added products or cell reprogramming or editing. India has also world-class research institutions with state-of-art infrastructure facility like IISc Bangalore, NCBS Bangalore, CCMB Hyderabad, IGIB New Delhi, CDRI Lucknow, NII New Delhi, AIIMS New Delhi, ICGEB New Delhi or new specialized synthetic biology centre. Indian funding agencies such as DST, DBT, ICAR, CSIR, DRDO and ICMR should also promote the synthetic biology research by making task force and prioritizing it as a major thrust area, research and innovation. The communal effort should be needed to promote and accelerate the synthetic biology research in India thus, we can also compete globally.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 12217
  • [From(publication date):
    December-2014 - May 22, 2018]
  • Breakdown by view type
  • HTML page views : 8393
  • PDF downloads : 3824
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7